SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: celeryroot.com who wrote (24419)8/12/1998 5:37:00 PM
From: ewolf  Read Replies (4) | Respond to of 32384
 
On businesswire--Seragen merger approved by shareholders.



To: celeryroot.com who wrote (24419)8/14/1998 9:01:00 AM
From: Henry Niman  Read Replies (1) | Respond to of 32384
 
Did Flanders file to sell or did the filing show that he did sell on Aug 4?:

LIGAND AFFILIATE FILES FORM 144, TO SELL SHARES

WASHINGTON, DC, Aug. 13, 1998 (States via COMTEX) -- Lloyd Flanders, an affiliate of Ligand Pharmaceuticals of San Diego, Calif., reported on Aug. 7, 1998, the proposed sale of 63,750 shares on Aug. 4, 1998, for $669,375 through Smith Barney.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News